Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report
In: ISSN: 0077-8923, 2022
academicJournal
Zugriff:
International audience ; The COVID-19 pandemic caught the world largely unprepared, including scientific and policy communities. On April 10-13, 2022, researchers across academia, industry, government, and nonprofit organizations met at the Keystone symposium "Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases" to discuss the successes and challenges of the COVID-19 pandemic and what lessons can be applied moving forward. Speakers focused on experiences not only from the COVID-19 pandemic but also from outbreaks of other pathogens, including the Ebola virus, Lassa virus, and Nipah virus. A general consensus was that investments made during the COVID-19 pandemic in infrastructure, collaborations, laboratory and manufacturing capacity, diagnostics, clinical trial networks, and regulatory enhancements-notably, in low-to-middle income countries-must be maintained and strengthened to enable quick, concerted responses to future threats, especially to zoonotic pathogens.
| Titel: |
Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report
|
|---|---|
| Autor/in / Beteiligte Person: | Cable, Jennifer ; Fauci, Anthony ; Dowling, William, E ; Günther, Stephan ; Bente, Dennis, A ; Yadav, Pragya, Dhruv ; Madoff, Lawrence, C ; Wang, Lin‐fa ; Arora, Rahul, K ; van Kerkhove, Maria ; Chu, May, C ; Jaenisch, Thomas ; Epstein, Jonathan, H ; Frost, Simon, David William ; Bausch, Daniel, G ; Hensley, Lisa, E ; Bergeron, Éric ; Sitaras, Ioannis ; Gunn, Michael, D ; Geisbert, Thomas, W ; Muñoz‐fontela, César ; Krammer, Florian ; de Wit, Emmie ; Nordenfelt, Pontus ; Saphire, Erica, Ollmann ; Gilbert, Sarah, C ; Corbett, Kizzmekia, S ; Branco, Luis, M ; Baize, Sylvain ; van Doremalen, Neeltje ; Krieger, Marco, A ; Clemens, Sue, Ann Costa ; Hesselink, Renske ; Hartman, Dan ; National Institute of Allergy and Infectious Diseases Bethesda (NIAID-NIH) ; National Institutes of Health Bethesda (NIH) ; Coalition for Epidemic Preparedness Innovations Oslo (CEPI) ; Bernhard Nocht Institute for Tropical Medicine - Bernhard-Nocht-Institut für Tropenmedizin Hamburg, Germany (BNITM) ; University of Texas Medical Branch at Galveston ; California Institute of Technology (CALTECH) ; National Institute of Virology - National Influenza Center Pune, India (NIV) ; University of Massachusetts System (UMASS) ; Duke-NUS Medical School Singapore ; University of Calgary ; University of Oxford ; Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO) ; University of Colorado Anschutz Aurora ; EcoHealth Alliance New York ; Microsoft Research Redmond ; Microsoft Corporation Redmond, Wash. ; Foundation for Innovative New Diagnostics (FIND) ; PREVAIL ; Centers for Disease Control and Prevention Atlanta (CDC) ; Centers for Disease Control and Prevention ; Johns Hopkins Bloomberg School of Public Health Baltimore ; Johns Hopkins University (JHU) ; Duke University Durham ; University of Manitoba Winnipeg ; Icahn School of Medicine at Mount Sinai New York (MSSM) ; Skane University Hospital Lund ; La Jolla Institute for Immunology La Jolla, CA, États-Unis ; Harvard T.H. Chan School of Public Health ; Labs, Zalgen ; Biologie des Infections Virales Émergentes - Biology of Emerging Viral Infections (UBIVE) ; Centre International de Recherche en Infectiologie (CIRI) ; École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL) ; Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL) ; Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur Paris (IP) ; Fiocruz Paraná - Instituto Carlos Chagas / Carlos Chagas Institute Curitiba, Brésil (ICC) ; Fundação Oswaldo Cruz / Oswaldo Cruz Foundation (FIOCRUZ) ; Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP) ; Università degli Studi di Siena = University of Siena (UNISI) ; Bill & Melinda Gates Foundation Seattle ; R.K.A. and M.V.K. presented work funded by the WHO Solidarity Response Fund and the German Federal Ministry of Health COVID-19 Research and Development. R.K.A. would also like to thank the following additional funders of SeroTracker's SARS-CoV-2 evidence synthesis efforts: the Public Health Agency of Canada through Canada's COVID-19 Immunity Task Force, the Robert Koch Institute, and the Canadian Medical Association Joule Innovation Fund. M.V.K. is employed by the WHO ; the authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions, policies, or views of WHO. E.d.W. and N.v.D. are supported by the Intramural Research Program of NIAID, NIH. |
| Link: | |
| Zeitschrift: | ISSN: 0077-8923, 2022 |
| Veröffentlichung: | HAL CCSD ; Wiley, 2022 |
| Medientyp: | academicJournal |
| DOI: | 10.1111/nyas.14898 |
| Schlagwort: |
|
| Sonstiges: |
|